Skip to main content
Log in

Viral-mediated FGF-2 treatment of the constant light damage model of photoreceptor degeneration

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

These experiments evaluate overexpression of basic fibroblast growth factor (FGF-2) as a treatment to decrease photoreceptor cell death in the constant light damage model of retinal degeneration. Increased FGF-2 expression was accomplished by gene transfer to the retina via injection into the subretinal space of a recombinant adeno-associated virus (rAAV), containing the FGF-2 gene. Rescue effects were assessed by morphometry and electroretinographic analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Noell WK, Walker VS, et al. Retinal damage by light in rats. Invest Ophthalmol 1966; 5(5): 450–73.

    Google Scholar 

  2. Faktorovich EG, Steinberg RH, et al. Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J Neurosci 1992: 12(9): 3554–67.

    Google Scholar 

  3. LaVail MM, Unoki K, et al. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA 1992; 89(23): 11249–53.

    Google Scholar 

  4. Unoki K, LaVail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 1994; 35(3): 907–15.

    Google Scholar 

  5. Masuda K, Watanabe I, et al. Functional Rescue of photoreceptors from the damaging effects of constant light by survival-promoting factors in the rat. Invest Ophthalmol Vis Sci 1995; 36(10): 2142–6.

    Google Scholar 

  6. LaVail MM, Yasumura D, et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci 1998; 39(3): 592–602.

    Google Scholar 

  7. Liu C, Peng M, et al. Preconditioning with bright light evokes a protective response against light damage in the rat retina. J Neurosci 1998; 18(4): 1337–44.

    Google Scholar 

  8. Ranchon I, Gorrand JM, et al. Functional protection of photoreceptors from light-induced damage by dimethylthiourea and Ginkgo biloba extract. Invest Ophthalmol Vis Sci 1999; 40(6): 1191–9.

    Google Scholar 

  9. Wiegand RD, Giusto NM, et al. Evidence for rod outer segment lipid peroxidation following constant illumination of the rat retina. Invest Ophthalmol Vis Sci 1983; 24(10): 1433–5.

    Google Scholar 

  10. Akpalaba CO, AC Oraedu, et al. Biochemical studies on the effects of continuous light on the albino rat retina. Exp Eye Res 1986; 42(1): 1–9.

    Google Scholar 

  11. Lisman J, Fain G. Support for the equivalent light hypothesis for RP. Nat Med 1995; 1(12): 1254–5.

    Google Scholar 

  12. Lau D, McGee LH, et al. Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci 2000; 41(11): 3622–33.

    Google Scholar 

  13. LaVail MM, Gorrin GM, Repaci MA, Thomas LA, Ginsberg HM. Genetic regulation of light damage to photoreceptors Invest Ophthalmol Vis Sci 1987; 28: 1043–8.

    Google Scholar 

  14. Flannery JG, Zolotukhin S, et al. Efficient photoreceptortargeted gene expression in vivo by recombinant adeno associated virus. Proc Nat Acad Sci USA 1997; 94(13): 6916–21.

    Google Scholar 

  15. McGee Sanftner LH, Abel H, et al. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther 2001; 4(6): 622–9.

    Google Scholar 

  16. McGee Sanftner LH, Rendahl KG, et al. Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina. Mol Ther 2001; 3(5 Pt 1): 688–96.

    Google Scholar 

  17. Bachoud-Levi AC, Deglon N, et al. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum Gene Ther 2000; 11(12): 1723–9.

    Google Scholar 

  18. Aebischer P, Schluep M, et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients [published erratum appears in Nat Med 1996; 2(9): 1041. Nat Med 1996; 2(6): 696–9.

    Google Scholar 

  19. Mandel RJ, Spratt SK, et al. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci USA 1997; 94(25): 14083–8.

    Google Scholar 

  20. Bilang-Bleuel A, Revah F, et al. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci USA 1997; 94(16): 8818–23.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lau, D., Flannery, J. Viral-mediated FGF-2 treatment of the constant light damage model of photoreceptor degeneration. Doc Ophthalmol 106, 89–98 (2003). https://doi.org/10.1023/A:1022481306146

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022481306146

Navigation